DSFIR — DSM-Firmenich AG Share News
0.000.00%
IndustrialsBalancedLarge Cap
- €26.27bn
- €28.77bn
- €9.03bn
Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK
Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Dsm-firmenich raises growth outlook in line with expectations (updated)
Dsm-firmenich slips as slight Q3 beat, guidance hike 'not enough'
Dsm-firmenich posts Q3 results slightly above expectations, raises growth outlook
Brief: Dsm-firmenich Q3 Results Beat Consensus, 2026 Growth Outlook Lifted
Givaudan jumps on fragrance outperformance; peers follow
Europe Research Roundup: Barratt Redrow, Man Group, Sika
Europe Research Roundup: BP, KPN, VAAR
Brief: DSM-Firmenich Completes Karawang Manufacturing Expansion
Next cycle in ingredient makers sector belongs to biotech, Jefferies says
Europe Research Roundup: DSM-Firmenich, Merck, Orsted
Brief: DSM-Firmenich Initiates Patent Infringement Litigation In China
Brief: DSM-Firmenich Proposes Richard Ridinger As New Chairman
Top of the Street: Smith & Nephew, DSM, Beiersdorf, Generali
Europe Research Roundup: DSM-Firmenich, Nexans, Rightmove
Europe Research Roundup: Bawag Group, Natwest Group, Mersen
European chemical firms post solid Q2 results but stay cautious on outlook